Literature DB >> 30856253

Eosinophils in Inflammatory Bowel Disease.

Rhiannon T Filippone1, Lauren Sahakian1, Vasso Apostolopoulos1, Kulmira Nurgali1,2,3.   

Abstract

Clinical investigations in inflammatory bowel disease (IBD) patients have provided increasing evidence that eosinophils contribute to chronic intestinal inflammation. Accumulation of eosinophils in the gastrointestinal tract correlates with the variations of eosinophil regulatory molecules; however, their role in gastrointestinal dysfunction in IBD has not been fully elucidated. This review will describe the development and characterization of gastrointestinal eosinophils, mechanisms of eosinophil recruitment to the gastrointestinal tract. Moreover, the eosinophil-induced changes to the enteric nervous system associated with disease severity and gastrointestinal dysfunction will be analyzed with suggestive molecular pathways for enteric neuronal injury. Current and potential therapeutic interventions targeting eosinophils will be discussed.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CCR3-eotaxin axis; Eosinophils; IBD; enteric neurons

Mesh:

Year:  2019        PMID: 30856253     DOI: 10.1093/ibd/izz024

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

2.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

3.  The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer.

Authors:  Vanessa Barriga; Nyanbol Kuol; Kulmira Nurgali; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2019-08-19       Impact factor: 6.575

Review 4.  Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain?

Authors:  Inge Jacobs; Matthias Ceulemans; Lucas Wauters; Christine Breynaert; Séverine Vermeire; Bram Verstockt; Tim Vanuytsel
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

Review 5.  Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.

Authors:  Dickson Kofi Wiredu Ocansey; Bing Pei; Xinwei Xu; Lu Zhang; Chinasa Valerie Olovo; Fei Mao
Journal:  J Transl Med       Date:  2021-06-10       Impact factor: 5.531

6.  Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.

Authors:  Georgios Katinios; Maite Casado-Bedmar; Susanna A Walter; Maria Vicario; Ana M González-Castro; Olga Bednarska; Johan D Söderholm; Henrik Hjortswang; Åsa V Keita
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

7.  Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity.

Authors:  Rodrigo Jiménez-Saiz; Varun C Anipindi; Heather Galipeau; Yosef Ellenbogen; Roopali Chaudhary; Joshua F Koenig; Melissa E Gordon; Tina D Walker; Talveer S Mandur; Soumeya Abed; Alison Humbles; Derek K Chu; Jonas Erjefält; Kjetil Ask; Elena F Verdú; Manel Jordana
Journal:  Front Immunol       Date:  2020-02-13       Impact factor: 7.561

8.  Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease.

Authors:  Nada Abedin; Teresa Seemann; Sandra Kleinfeld; Jessica Ruehrup; Stefani Röseler; Christian Trautwein; Konrad Streetz; Gernot Sellge
Journal:  J Clin Med       Date:  2019-11-20       Impact factor: 4.241

9.  Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Eloísa Salvo-Romero; Cristina Martínez; Beatriz Lobo; Bruno K Rodiño-Janeiro; Marc Pigrau; Alejandro D Sánchez-Chardi; Ana M González-Castro; Marina Fortea; Cristina Pardo-Camacho; Adoración Nieto; Elba Expósito; Danila Guagnozzi; Amanda Rodríguez-Urrutia; Inés de Torres; Ricard Farré; Fernando Azpiroz; Carmen Alonso-Cotoner; Javier Santos; María Vicario
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

10.  Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart.

Authors:  Xiao Chen; Mei-Zhen Zhao; Bei-Ping Miao; Zhi-Qiang Liu; Gui Yang; Jiang-Qi Liu; Ping-Chang Yang; Jiang-Ping Song
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.